China

(Image: Getty/hailshadow)

GSK’s shingles vaccine approved in China

By Maggie Lynch

GSK is investing in ‘significant’ capacity expansion to support production of its shingles vaccine, which has been approved in China after clinical trials demonstrated 90% efficacy.

Top ten stories of the month

Top ten stories of the month

By Ben Hargreaves

This month’s round-up of the most popular stories of the month, featuring a bold prediction of future growth for Chinese biotech and bad news for a potential treatment for Alzheimer’s disease.